Patients' accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression

Abstract

Objective: To identify patients' perceptions of the value of psilocybin as a treatment for depression. Method: Twenty patients enrolled in an open-label trial of psilocybin for treatment-resistant depression participated in a semistructured interview at 6-month follow …